Charles Schwab Investment Management »

SAB Biotherapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of SAB Biotherapeutics shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in SAB Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including SAB Biotherapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SAB Biotherapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $11k 16k 0.69
2023-09-30 $10k 16k 0.63
2023-06-30 $14k 16k 0.83
2023-03-31 $7.1k 16k 0.44
2022-12-31 $9.6k 16k 0.59
2022-09-30 $12k 16k 0.74
2022-06-30 $24k 16k 1.48
2021-12-31 $79k 10k 7.90